These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24642963)

  • 1. Pharmacological inhibition of TPL2/MAP3K8 blocks human cytotoxic T lymphocyte effector functions.
    Chowdhury FZ; Estrada LD; Murray S; Forman J; Farrar JD
    PLoS One; 2014; 9(3):e92187. PubMed ID: 24642963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor progression locus 2 (Map3k8) is critical for host defense against Listeria monocytogenes and IL-1 beta production.
    Mielke LA; Elkins KL; Wei L; Starr R; Tsichlis PN; O'Shea JJ; Watford WT
    J Immunol; 2009 Dec; 183(12):7984-93. PubMed ID: 19933865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tpl2 kinase regulates T cell interferon-gamma production and host resistance to Toxoplasma gondii.
    Watford WT; Hissong BD; Durant LR; Yamane H; Muul LM; Kanno Y; Tato CM; Ramos HL; Berger AE; Mielke L; Pesu M; Solomon B; Frucht DM; Paul WE; Sher A; Jankovic D; Tsichlis PN; O'Shea JJ
    J Exp Med; 2008 Nov; 205(12):2803-12. PubMed ID: 19001140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
    Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT
    J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TPL2 Kinase Is a Crucial Signaling Factor and Mediator of NKT Effector Cytokine Expression in Immune-Mediated Liver Injury.
    Vyrla D; Nikolaidis G; Oakley F; Perugorria MJ; Tsichlis PN; Mann DA; Eliopoulos AG
    J Immunol; 2016 May; 196(10):4298-310. PubMed ID: 27053764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TPL2 kinase regulates the inflammatory milieu of the myeloma niche.
    Hope C; Ollar SJ; Heninger E; Hebron E; Jensen JL; Kim J; Maroulakou I; Miyamoto S; Leith C; Yang DT; Callander N; Hematti P; Chesi M; Bergsagel PL; Asimakopoulos F
    Blood; 2014 May; 123(21):3305-15. PubMed ID: 24723682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Progression Locus 2 Promotes Induction of IFNλ, Interferon Stimulated Genes and Antigen-Specific CD8+ T Cell Responses and Protects against Influenza Virus.
    Kuriakose T; Tripp RA; Watford WT
    PLoS Pathog; 2015 Aug; 11(8):e1005038. PubMed ID: 26241898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tpl2 Promotes Innate Cell Recruitment and Effector T Cell Differentiation To Limit Citrobacter rodentium Burden and Dissemination.
    Acuff NV; Li X; Latha K; Nagy T; Watford WT
    Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28760932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor progression locus 2 differentially regulates IFNγ and IL-17 production by effector CD4+ T cells in a T cell transfer model of colitis.
    Acuff NV; Li X; Kirkland R; Nagy T; Watford WT
    PLoS One; 2015; 10(3):e0119885. PubMed ID: 25781948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Tpl2 Kinase Regulates the COX-2/Prostaglandin E2 Axis in Adipocytes in Inflammatory Conditions.
    Berthou F; Ceppo F; Dumas K; Massa F; Vergoni B; Alemany S; Cormont M; Tanti JF
    Mol Endocrinol; 2015 Jul; 29(7):1025-36. PubMed ID: 26020725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ablation of tumor progression locus 2 promotes a type 2 Th cell response in Ovalbumin-immunized mice.
    Watford WT; Wang CC; Tsatsanis C; Mielke LA; Eliopoulos AG; Daskalakis C; Charles N; Odom S; Rivera J; O'Shea J; Tsichlis PN
    J Immunol; 2010 Jan; 184(1):105-13. PubMed ID: 19955521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memory CD8+ T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen.
    Berg RE; Crossley E; Murray S; Forman J
    J Exp Med; 2003 Nov; 198(10):1583-93. PubMed ID: 14623912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tpl2 kinase is upregulated in adipose tissue in obesity and may mediate interleukin-1beta and tumor necrosis factor-{alpha} effects on extracellular signal-regulated kinase activation and lipolysis.
    Jager J; Grémeaux T; Gonzalez T; Bonnafous S; Debard C; Laville M; Vidal H; Tran A; Gual P; Le Marchand-Brustel Y; Cormont M; Tanti JF
    Diabetes; 2010 Jan; 59(1):61-70. PubMed ID: 19808894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cot/Tpl2 regulates IL-23 p19 expression in LPS-stimulated macrophages through ERK activation.
    Kakimoto K; Musikacharoen T; Chiba N; Bandow K; Ohnishi T; Matsuguchi T
    J Physiol Biochem; 2010 Mar; 66(1):47-53. PubMed ID: 20405269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tpl2 promotes neutrophil trafficking, oxidative burst, and bacterial killing.
    Acuff NV; Li X; Elmore J; Rada B; Watford WT
    J Leukoc Biol; 2017 Jun; 101(6):1325-1333. PubMed ID: 28356348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential requirements of CD4(+) T-cell signals for effector cytotoxic T-lymphocyte (CTL) priming and functional memory CTL development at higher CD8(+) T-cell precursor frequency.
    Umeshappa CS; Nanjundappa RH; Xie Y; Freywald A; Xu Q; Xiang J
    Immunology; 2013 Apr; 138(4):298-306. PubMed ID: 23113741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor progression locus 2 (Tpl2) kinase promotes chemokine receptor expression and macrophage migration during acute inflammation.
    Rowley SM; Kuriakose T; Dockery LM; Tran-Nguyen T; Gingerich AD; Wei L; Watford WT
    J Biol Chem; 2014 May; 289(22):15788-97. PubMed ID: 24713702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TPL-2-ERK1/2 signaling promotes host resistance against intracellular bacterial infection by negative regulation of type I IFN production.
    McNab FW; Ewbank J; Rajsbaum R; Stavropoulos E; Martirosyan A; Redford PS; Wu X; Graham CM; Saraiva M; Tsichlis P; Chaussabel D; Ley SC; O'Garra A
    J Immunol; 2013 Aug; 191(4):1732-43. PubMed ID: 23842752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplifying IFN-γ Signaling in Dendritic Cells by CD11c-Specific Loss of SOCS1 Increases Innate Immunity to Infection while Decreasing Adaptive Immunity.
    Alice AF; Kramer G; Bambina S; Baird JR; Bahjat KS; Gough MJ; Crittenden MR
    J Immunol; 2018 Jan; 200(1):177-185. PubMed ID: 29150567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cells activated by an anti-inflammatory agent induce CD4(+) T helper type 2 responses without impairing CD8(+) memory and effector cytotoxic T-lymphocyte responses.
    Wang Y; Da'Dara AA; Thomas PG; Harn DA
    Immunology; 2010 Mar; 129(3):406-17. PubMed ID: 19922421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.